CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$53.55 USD
+0.26 (0.49%)
Updated May 9, 2024 04:00 PM ET
After-Market: $53.52 -0.03 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.67 | 0.00% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of -$1.43 per share, beating the Zacks Consensus Estimate of $-1.63 per share. This reflects a positive earnings surprise of 12.27%. Look out for CRSP's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.67 per share, reflecting a year-over-year decrease of 70.41%.
Earnings History
Price & Consensus
Zacks News for CRSP
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services